116 related articles for article (PubMed ID: 38547000)
1. Mixed Supervision of Histopathology Improves Prostate Cancer Classification from MRI.
Rajagopal A; Westphalen AC; Velarde N; Simko JP; Nguyen H; Hope TA; Larson PEZ; Magudia K
IEEE Trans Med Imaging; 2024 Mar; PP():. PubMed ID: 38547000
[TBL] [Abstract][Full Text] [Related]
2. Bridging the gap between prostate radiology and pathology through machine learning.
Bhattacharya I; Lim DS; Aung HL; Liu X; Seetharaman A; Kunder CA; Shao W; Soerensen SJC; Fan RE; Ghanouni P; To'o KJ; Brooks JD; Sonn GA; Rusu M
Med Phys; 2022 Aug; 49(8):5160-5181. PubMed ID: 35633505
[TBL] [Abstract][Full Text] [Related]
3. Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI.
Arif M; Schoots IG; Castillo Tovar J; Bangma CH; Krestin GP; Roobol MJ; Niessen W; Veenland JF
Eur Radiol; 2020 Dec; 30(12):6582-6592. PubMed ID: 32594208
[TBL] [Abstract][Full Text] [Related]
4. Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.
Schelb P; Kohl S; Radtke JP; Wiesenfarth M; Kickingereder P; Bickelhaupt S; Kuder TA; Stenzinger A; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
Radiology; 2019 Dec; 293(3):607-617. PubMed ID: 31592731
[TBL] [Abstract][Full Text] [Related]
5. Selective identification and localization of indolent and aggressive prostate cancers via CorrSigNIA: an MRI-pathology correlation and deep learning framework.
Bhattacharya I; Seetharaman A; Kunder C; Shao W; Chen LC; Soerensen SJC; Wang JB; Teslovich NC; Fan RE; Ghanouni P; Brooks JD; Sonn GA; Rusu M
Med Image Anal; 2022 Jan; 75():102288. PubMed ID: 34784540
[TBL] [Abstract][Full Text] [Related]
6. Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram.
Bjurlin MA; Renson A; Rais-Bahrami S; Truong M; Rosenkrantz AB; Huang R; Taneja SS
Eur Urol Focus; 2019 Sep; 5(5):815-822. PubMed ID: 29802053
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
8. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.
Hosseinzadeh M; Saha A; Brand P; Slootweg I; de Rooij M; Huisman H
Eur Radiol; 2022 Apr; 32(4):2224-2234. PubMed ID: 34786615
[TBL] [Abstract][Full Text] [Related]
9. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
[TBL] [Abstract][Full Text] [Related]
10. Performance of multi-parametric magnetic resonance imaging through PIRADS scoring system in biopsy naïve patients with suspicious prostate cancer.
Nowier A; Mazhar H; Salah R; Shabayek M
Arab J Urol; 2022; 20(3):121-125. PubMed ID: 35935910
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
[TBL] [Abstract][Full Text] [Related]
12. Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Mischinger J; Schöllnast H; Zurl H; Geyer M; Fischereder K; Adelsmayr G; Igrec J; Fritz G; Merdzo-Hörmann M; Elstner J; Schmid J; Triebl A; Trimmel V; Reiter C; Steiner J; Rosenlechner D; Seles M; Pichler GP; Pichler M; Riedl J; Schöpfer-Schwab S; Strobl J; Hutterer GC; Zigeuner R; Pummer K; Augustin H; Ahyai S; Mannweiler S; Fuchsjäger M; Talakic E
Front Surg; 2022; 9():1013389. PubMed ID: 36277287
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer detection with magnetic resonance imaging (MRI)/ cognitive fusion biopsy: Comparing standard and targeted prostate biopsy with final prostatectomy histology.
Ryan J; Broe MP; Moran D; Mulvin D; Heffernan E; Swan N; Moran DE
Can Urol Assoc J; 2021 Sep; 15(9):E483-E487. PubMed ID: 33591900
[TBL] [Abstract][Full Text] [Related]
14. Fully Automatic Deep Learning in Bi-institutional Prostate Magnetic Resonance Imaging: Effects of Cohort Size and Heterogeneity.
Netzer N; Weißer C; Schelb P; Wang X; Qin X; Görtz M; Schütz V; Radtke JP; Hielscher T; Schwab C; Stenzinger A; Kuder TA; Gnirs R; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
Invest Radiol; 2021 Dec; 56(12):799-808. PubMed ID: 34049336
[TBL] [Abstract][Full Text] [Related]
15. Textured-Based Deep Learning in Prostate Cancer Classification with 3T Multiparametric MRI: Comparison with PI-RADS-Based Classification.
Liu Y; Zheng H; Liang Z; Miao Q; Brisbane WG; Marks LS; Raman SS; Reiter RE; Yang G; Sung K
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679484
[TBL] [Abstract][Full Text] [Related]
16. A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.
Miah S; Hosking-Jervis F; Connor MJ; Eldred-Evans D; Shah TT; Arya M; Barber N; Bhardwa J; Bott S; Burke D; Doherty A; Foster C; Freeman A; Hindley R; Jameson C; Karim O; Laniado M; Montgomery B; Nigam R; Punwani S; Sinclair A; Winkler M; Allen C; Ahmed HU
Eur Urol Oncol; 2020 Jun; 3(3):262-269. PubMed ID: 31411968
[TBL] [Abstract][Full Text] [Related]
17. Augmenting MRI-transrectal ultrasound-guided prostate biopsy with temporal ultrasound data: a clinical feasibility study.
Imani F; Zhuang B; Tahmasebi A; Kwak JT; Xu S; Agarwal H; Bharat S; Uniyal N; Turkbey IB; Choyke P; Pinto P; Wood B; Moradi M; Mousavi P; Abolmaesumi P
Int J Comput Assist Radiol Surg; 2015 Jun; 10(6):727-35. PubMed ID: 25843948
[TBL] [Abstract][Full Text] [Related]
18. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
Aldoj N; Lukas S; Dewey M; Penzkofer T
Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
[TBL] [Abstract][Full Text] [Related]
19. Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients.
El-Helaly HA; Mahmoud AA; Magdy AM; Hasehem A; Ibrahim HM; Mohamed KM; Ismail MH
J Egypt Natl Canc Inst; 2023 Mar; 35(1):5. PubMed ID: 36872409
[TBL] [Abstract][Full Text] [Related]
20. A Cascaded Deep Learning-Based Artificial Intelligence Algorithm for Automated Lesion Detection and Classification on Biparametric Prostate Magnetic Resonance Imaging.
Mehralivand S; Yang D; Harmon SA; Xu D; Xu Z; Roth H; Masoudi S; Sanford TH; Kesani D; Lay NS; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Acad Radiol; 2022 Aug; 29(8):1159-1168. PubMed ID: 34598869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
